15-17 November 2023
The University of Western Australia
Wilsmore & Tattershall Lecture Theatres
Perth, Western Australia
1 May - Call for abstracts open
15 August - Abstract submission close (extended)
30 August - Short talk notification (extended)
1 July - Early bird registration open
1 Aug - Regular registration open
30 Oct - Registration close
Registrations are now closedRegister now
Synthetic biology-inspired therapeutics are among the most exciting developments in the life sciences. From gene and RNA editing to engineered CAR-T-cells, these therapies have the potential to revolutionise the way we approach disease treatment. This theme will feature leading experts discussing the latest advances and applications of these cutting-edge technologies, and the strategies and trends shaping the future of this field. Attendees will gain valuable insights into the range of synthetic biology tools being used in therapeutic development, providing a foundation for further innovation and progress.
Bioactive small molecules have a wide range of applications in fields such as medicine, agriculture, and even materials science. This conference theme will explore the latest developments in synthetic biology-driven production of bioactive small molecules, including the use of metabolic engineering to unlock the potential of silent biosynthetic gene clusters. Experts in the field will discuss how the use of synthetic biology and metabolic engineering can lead to the discovery of novel bioactive small molecules and enable the production of these compounds at scale.
Biosensors and devices are essential components of synthetic biology, used to detect, measure, and interact with biological or abiotic systems. This theme will focus on the establishment, improvement, and applications of biosensors and devices in areas such as environmental and health-related contexts. From real-time monitoring of contaminants to personalised medicine, biosensors and devices offer new opportunities for understanding and interacting with living systems, and addressing some of the most pressing challenges facing our world today.
This theme will explore the role of synthetic biology in applied biocatalysis, driven by environmental and economic incentives for using enzymes in the synthesis of various pharmaceutical and industrially important chemicals. Engineered enzymes can now outperform the best chemocatalytic alternatives, but custom engineering of a robust biocatalyst remains a time-consuming process. Recent advances in ultrahigh-throughput screening, mutational scanning, DNA synthesis, metagenomics, and machine learning will soon make it possible to accelerate the tailor design of novel biocatalysts, providing significant opportunities for synthetic biologists.
The future of materials lies in the realm of biology, where synthetic biology is playing an increasingly pivotal role in advancing our understanding of living systems and the creation of sustainable materials. With the ability to engineer organisms and systems at the genetic level, synthetic biology presents unprecedented opportunities for the development of materials with enhanced properties and functionalities. From self-assembled nanostructures and living concrete, to functional clothing and advanced medical implants, the potential for synthetic biology in material design is vast and continually expanding.
Synthetic biology is playing an increasingly important role in advancing metabolic engineering, offering unprecedented opportunities to engineer organisms and biological systems to produce sustainable solutions to pressing environmental problems. From biofuels and bioplastics to carbon capture and waste remediation, synthetic biology is helping to reduce the impacts of a changing environment and address some of the most pressing environmental challenges we face today.
Plant synthetic biology will revolutionize agriculture and transform our food systems. By utilizing advanced genetic engineering tools, we will be able to develop crops that are more resilient to environmental stressors such as drought, pests, and disease. Additionally, we will be able to create plants that produce higher yields, and are more nutritious and flavorful. As plant synthetic biology continues to advance, we may even be able to engineer plants to produce novel products, such as medicines or biofuels.
This special session will explore what it takes to translate synthetic biology research into industrial success stories. Attendees will hear from experts in the field on leveraging the potential of synthetic biology to drive growth and innovation in the Australian bioeconomy. The session will provide valuable insights into strategies for investment and growth, as well as highlight the significant impact synthetic biology can have on industries such as agriculture, manufacturing, and biotechnology.
Join leading experts in the field to explore the cutting-edge tools and techniques driving synthetic biology. From genome engineering tools like CRISPR-Cas9, to high-throughput screening methods and protein engineering platforms, this session offers a deep dive into the latest advancements in synthetic biology research. You'll gain valuable insights into the diverse range of tools and applications available, and discover the key trends and strategies shaping the future of the field. This is an essential opportunity for anyone interested in staying up-to-date with the latest advancements in synthetic biology, and learn how these tools are applied across different organisms and applications.
Transitioning from an academic setting to the professional world can be a daunting prospect. However, the field of synthetic biology offers vast opportunities for scientists to transform their laboratory concepts into practical applications within industry. Whether through the establishment of a personal start-up or by contributing to the advancement of various manufacturing processes, the biotechnology industry presents a promising avenue for the fulfilment of synthetic biologists' career aspirations.
As engineers of the biological world, it is our responsibility to ensure the safety of our organisms, devices, and materials for the environment. The early emergence of recombinant DNA technologies and biosecurity meetings like the Asilomar Conference on Recombinant DNA in California in 1975 marked an integral part of biotechnology and the soon-to-emerge field of synthetic biology. Since then, it has been essential for synthetic biologists to consider the potential consequences of their work. We want to discuss what ethical boundaries we face in our work and what social responsibility we have to the broader public.
Registration includes all morning and afternoon teas, lunches, an excursion, and the conference dinner. Click the link below for pricing information and to book your spot!
We are grateful to the sponsors of SBA’23! If you would like to become a sponsor please email us.
Georg Fritz (The University of Western Australia)
Andrew Marshall (The University of Western Australia), Anwar Sunna (Macquarie University), Birgitta Ebert (The University of Queensland), Cameron Evans (The University of Western Australia), Charlotte Williams (CSIRO), Jessica Kretzmann (The University of Western Australia), Mark Calcott (Victoria University of Wellington), Oliver Mead (CSIRO), Patrick Schilling (CSIRO), Rashika Sood (Macquarie University), Rebecca Wolters (The University of Western Australia), Tara Pukala (The University of Adelaide), Yit-Heng-Chooi (The University of Western Australia)
Archa Fox (The University of Western Australia), Bernd Rehm (Griffith University), Elizabeth Gillam (The University of Queensland), Emily Parker (Victoria University of Wellington), Esteban Marcellin Saldana (The University of Queensland), Ionat Zurr (The University of Western Australia), Jenny Mortimer (The University of Adelaide), Keith Shearwin (The University of Adelaide), Kirill Alexandrov (Queensland University of Technology), Robert Speight (CSIRO)
Become a member today to stay up to date with all things Synthetic Biology and access our exclusive network of synthetic biologists, scientists, coders, designers, investors.Find out more